Pfizer Inc. - Comment

Document ID: FDA-2011-D-0436-0007
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: August 30 2011, at 12:00 AM Eastern Daylight Time
Date Posted: September 7 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: June 29 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: September 1 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f09280
View Document:  View as format xml

View Comment

Attached please find the Pfizer comments to the draft guidance on Q11

Attachments:

Pfizer Inc. - Comment

Title:
Pfizer Inc. - Comment

View Attachment: View as format msw8 View as format pdf

Related Comments

    View All
Total: 23
AstraZeneca - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0004

Sep 01,2011 11:59 PM ET
MedImmune - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0005

Sep 01,2011 11:59 PM ET
Johnson and Johnson Pharmaceutical Research and Development, LLC - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0006

Sep 01,2011 11:59 PM ET
Pfizer Inc. - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0007

Sep 01,2011 11:59 PM ET
Shire Pharmaceuticals Inc. - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0008

Sep 01,2011 11:59 PM ET